Cognate BioServices, a Charles River company, is a leading provider of custom development and cGMP manufacturing services tailored to a diverse range of autologous and allogeneic clinical and commercial cell and gene therapy applications. The company is dedicated to supporting all clinical phases of product development and manufacturing, with a particular focus on mid to late-phase trials that prioritise scale-up and commercial manufacturing. Cognate BioServices is equipped with commercial capacity and PAI readiness, enabling clients to effectively scale their operations. The company offers a variety of solutions, including plasmid synthesis, gene replacement, screening, vector development, and viral vector manufacturing.

Services include:
- Custom development and cGMP manufacturing
- Plasmid synthesis and supply (from 50mg to 500mg of purified plasmids)
- Gene replacement and screening
- Vector development including plasmid and strain construction
- Viral vector manufacturing
- Cellular immunotherapy
- cGMP cell therapy manufacturing
- Cold storage
- Finished dosage formulation
- Packaging

Cognate BioServices, a Charles River company, is committed to excellence in the field of biotechnology and provides comprehensive services that meet the needs of its clients in the pharmaceutical industry. For more information, please visit cognatebioservices.com.